Author

Anna Clennon

Observed name: Clennon, Anna

Institution: Aurora St. Luke's Medical Center

Observed institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Aurora St. Luke's Medical Center, The Ohio State University

ORCID: 0000-0002-3787-9296

Observed ORCID: 0000-0002-3787-9296

OpenAlex ID: A5024913509

Effect of Intravenous Immunoglobulin (IVIG) Supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma

2025 · Meera Mohan, Aniko Szabo, et al. · Blood Cancer Journal · 52

Effects of Intravenous Immunoglobulin Supplementation (IVIG) on Infections in Recipients of Teclistamab Therapy for Multiple Myeloma (MM): A Multi-Institutional Study

2024 · Heloise Cheruvalath, Anna Clennon, et al. · Blood · 12

Effect of Enfortumab Vedotin Dose Adjustment on Efficacy in Metastatic Urothelial Carcinoma: A Retrospective Single-Center Experience

2023 · Anna Clennon, Megan Hinkley, et al. · Cancer Management and Research · 7

Efficacy and safety of immune checkpoint inhibitors in metastatic penile squamous cell carcinoma: a retrospective multicenter analysis

2025 · Timothy Schieber, Kelly Brunk, et al. · Experimental Hematology and Oncology · 6

Efficacy and safety of immune checkpoint inhibitors (ICI) for the treatment of metastatic penile squamous cell carcinoma (mPSCC).

2025 · Tiewei Cheng, Timothy J. Schieber, et al. · Journal of Clinical Oncology

Works count: 7

Citation count: 77

H-index: 4

I10-index: 2